Award recordCONTRACT

CSL BEHRING L.L.C.

PIID 36C24718F0668· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2018· $552,774 net obligations· UEI H3WKVE9VBLY3· PA

Description

CARIMUNE 6GM/CARIMUNE 12GM/PRIVIGEN 10GM VIALS

First action · last action
2018-02-01 · 2019-08-22
Transactions
3
First transaction's obligation
$493,127
Base + all options value (sum of deltas)
$552,774
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D50358
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$749,735$0Base award · 2018-02-01 · this action $493,127 · running total $493,127Modification P00001 · 2018-09-27 · this action $256,608 · running total $749,735Modification P00002 · 2019-08-22 · this action -$196,961 · running total $552,774
  • Base2018-02-01+$493,127= $493,127
  • Mod P000012018-09-27+$256,608= $749,735
  • Mod P000022019-08-22-$196,961= $552,774
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-02-01+$493,127$493,127CARIMUNE 6GM/CARIMUNE 12GM/PRIVIGEN 10GM VIALS
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2018-09-27+$256,608$749,735CARIMUNE 6GM/CARIMUNE 12GM/PRIVIGEN 10GM VIALS
Mod P00002· CHANGE ORDER2019-08-22−$196,961$552,774CARIMUNE 6GM/CARIMUNE 12GM/PRIVIGEN 10GM VIALS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI H3WKVE9VBLY3)

AwardOffice · PSC / listingNet obligationsFY
36C24826F0207248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$183,903FY2026
36C24826F0187248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$36,781FY2026
36C25226F0318252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS$85,484FY2026
36C24826F0091248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$147,122FY2026
36C24826F0037248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$124,240FY2026
36C24824F0327248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS$391,583FY2024

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24718F0668_3600_V797D50358_3600 · retrieved 2026-09-26.